No Data
No Data
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $6,600 Today
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
The trend of weight loss drug sector in US stock market is diverging. Novo Nordisk (NVO.US) and Eli Lilly and Co (LLY.US) face challenges to their duopoly.
As more and more pharmaceutical companies enter the lucrative weight loss drug market to get a share of the pie, the increasing competition is making investors worried about the duopoly position of Novo Nordisk and Eli Lilly and Co in this market.
Viking Therapeutics, Inc. (VKTX) Gains As Market Dips: What You Should Know
Should Viking (VKTX) Stock Be in Your Portfolio Pre-Q2 Earnings?
Is Viking Therapeutics a Millionaire-Maker?
No Data